Body mass index trajectories and prostate cancer risk: Results from the EPICAP study

被引:18
|
作者
Lavalette, Celine [1 ]
Cordina Duverger, Emilie [1 ]
Artaud, Fanny [1 ]
Rebillard, Xavier [2 ]
Lamy, Pierre-Jean [2 ,3 ]
Tretarre, Brigitte [4 ]
Cenee, Sylvie [1 ]
Menegaux, Florence [1 ]
机构
[1] Univ Paris Saclay, UVSQ, INSERM, CESP, Villejuif, France
[2] Clin Beau Soleil, Serv Urol, Montpellier, France
[3] Inst Med Anal Genom Imagenome, Labosud, Montpellier, France
[4] Registre Tumeurs Herault, Montpellier, France
来源
CANCER MEDICINE | 2020年 / 9卷 / 17期
关键词
body mass index; obesity; prostate cancer; trajectory; weight gain; DOSE-RESPONSE METAANALYSIS; SMOKING-CESSATION; WEIGHT-GAIN; OBESITY; INFLAMMATION; MORTALITY;
D O I
10.1002/cam4.3241
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Elevated body mass index (BMI) has been inconsistently associated with prostate cancer occurrence but it has been suggested that life course adulthood obesity may be associated with an increased risk of prostate cancer. However, few studies have investigated lifetime BMI and prostate cancer risk. We analyzed life course BMI trajectories on prostate cancer risk based on data from the Epidemiological study of Prostate Cancer (EPICAP). We included in our analyses 781 incident prostate cancer cases and 829 controls frequency matched by age. Participants were asked about their weight every decade from age 20 to two years before reference date. BMI trajectories were determined using group-based trajectory modeling to identify groups of men with similar patterns of BMI changes. We identified five BMI trajectories groups. Men with a normal BMI at age 20 developing overweight or obesity during adulthood were at increased risk of aggressive prostate cancer compared to men who maintained a normal BMI. Our results suggest that BMI trajectories resulting in overweight or obesity during adulthood are associated with an increased risk of aggressive prostate cancer, particularly in never smokers, emphasizing the importance of maintaining a healthy BMI throughout adulthood.
引用
收藏
页码:6421 / 6429
页数:9
相关论文
共 50 条
  • [1] BODY MASS INDEX TRAJECTORIES AND PROSTATE CANCER RISK IN THE EPICAP STUDY
    Lavalette, C.
    Duverger, E. Cordina
    Cenee, S.
    Rebillard, X.
    Lamy, P. J.
    Tretarre, B.
    Menegaux, F.
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2019, 73 : A33 - A34
  • [2] Occupation and prostate Cancer risk: results from the epidemiological study of prostate cancer (EPICAP)
    Bijoux, Wendy
    Cordina-Duverger, Emilie
    Balbolia, Soumaya
    Lamy, Pierre-Jean
    Rebillard, Xavier
    Tretarre, Brigitte
    Cenee, Sylvie
    Menegaux, Florence
    [J]. JOURNAL OF OCCUPATIONAL MEDICINE AND TOXICOLOGY, 2022, 17 (01)
  • [3] Night work and prostate cancer risk: results from the EPICAP Study
    Wendeu-Foyet, Meyomo Gaelle
    Bayon, Virginie
    Cenee, Sylvie
    Tretarre, Brigitte
    Rebillard, Xavier
    Cancel-Tassin, Geraldine
    Cussenot, Olivier
    Lamy, Pierre-Jean
    Faraut, Brice
    Ben Khedher, Soumaya
    Leger, Damien
    Menegaux, Florence
    [J]. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2018, 75 (08) : 573 - 581
  • [4] Occupation and prostate Cancer risk: results from the epidemiological study of prostate cancer (EPICAP)
    Wendy Bijoux
    Emilie Cordina-Duverger
    Soumaya Balbolia
    Pierre-Jean Lamy
    Xavier Rebillard
    Brigitte Tretarre
    Sylvie Cenee
    Florence Menegaux
    [J]. Journal of Occupational Medicine and Toxicology, 17
  • [5] ABDOMINAL OBESITY AND PROSTATE CANCER RISK: RESULTS FROM THE EPICAP STUDY
    Lavalette, C.
    Duverger, E. Cordina
    Cenee, S.
    Rebillard, X.
    Lamy, P. J.
    Tretarre, B.
    Menegaux, F.
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2019, 73 : A85 - A86
  • [6] Circadian genes and risk of prostate cancer: Findings from the EPICAP study
    Wendeu-Foyet, Meyomo G.
    Koudou, Yves
    Cenee, Sylvie
    Tretarre, Brigitte
    Rebillard, Xavier
    Cancel-Tassin, Geraldine
    Cussenot, Olivier
    Boland, Anne
    Bacq, Delphine
    Deleuze, Jean-Francois
    Lamy, Pierre-Jean
    Mulot, Claire
    Laurent-Puig, Pierre
    Truong, Therese
    Menegaux, Florence
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (07) : 1745 - 1753
  • [7] Sexually and non-sexually transmitted infections and the risk of prostate cancer: Results from the EPICAP study
    Sawaya, Melissa
    Cordina-Duverger, Emilie
    Lamy, Pierre-Jean
    Rebillard, Xavier
    Tretarre, Brigitte
    Menegaux, Florence
    [J]. CANCER MEDICINE, 2024, 13 (01):
  • [8] Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study
    Doat, Solene
    Cenee, Sylvie
    Tretarre, Brigitte
    Rebillard, Xavier
    Lamy, Pierre-Jean
    Bringer, Jean-Pierre
    Iborra, Francois
    Murez, Thibaut
    Sanchez, Marie
    Menegaux, Florence
    [J]. CANCER MEDICINE, 2017, 6 (10): : 2461 - 2470
  • [9] Body mass index, PSA, and prostate cancer risk
    Shannon, J.
    Palma, A. J.
    Peters, L.
    Garzotto, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Diabetes, metabolic syndrome and prostate cancer risk: Results from the EPICAP case-control
    Lavalette, Celine
    Cordina-Duverger, Emilie
    Rebillard, Xavier
    Lamy, Pierre-Jean
    Tretarre, Brigitte
    Cenee, Sylvie
    Menegaux, Florence
    [J]. CANCER EPIDEMIOLOGY, 2022, 81